‘FELUDA’ is billed as a cheaper, faster and simpler alternative to the standard RT-PCR diagnosis.
If you want to change selection, open document below and click on "Move attachment"
Unknown title for the SARS-CoV-2 virus, gathering all the intelligence and reagents along the way,” Chakraborty told PTI. And so in January itself, the team started working on a CRISPR-based COVID-19 test – <span>‘FELUDA’ is billed as a cheaper, faster and simpler alternative to the standard RT-PCR diagnosis. Named after Satyajit Ray's famed detective, the test is priced at an affordable Rs 500 and can deliver a result in 45 minutes. It is able to differentiate SARS-CoV-2 from other coronavi Summary
status | not read | | reprioritisations | |
---|
last reprioritisation on | | | suggested re-reading day | |
---|
started reading on | | | finished reading on | |
---|
Details